95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.25%
Revenue growth above 1.5x OR's 1.19%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
29.46%
Gross profit growth above 1.5x OR's 3.15%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
37.40%
Positive EBIT growth while OR is negative. John Neff might see a substantial edge in operational management.
37.40%
Positive operating income growth while OR is negative. John Neff might view this as a competitive edge in operations.
47.16%
Net income growth under 50% of OR's 26328.33%. Michael Burry would suspect the firm is falling well behind a key competitor.
40.00%
EPS growth under 50% of OR's 25100.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
40.00%
Diluted EPS growth under 50% of OR's 25100.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
8.38%
Share count expansion well above OR's 7.35%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
8.40%
Diluted share count expanding well above OR's 7.55%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
18.03%
OCF growth under 50% of OR's 74.50%. Michael Burry might suspect questionable revenue recognition or rising costs.
16.51%
FCF growth under 50% of OR's 76.16%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
122.35%
10Y CAGR of 122.35% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-11.80%
Negative 5Y CAGR while OR stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
3.37%
3Y CAGR of 3.37% while OR is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
103.41%
Positive long-term OCF/share growth while OR is negative. John Neff would see a structural advantage in sustained cash generation.
-35.46%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-12.92%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
19.00%
Below 50% of OR's 101.44%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-67.05%
Negative 5Y net income/share CAGR while OR is 101.44%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-31.11%
Negative 3Y CAGR while OR is 101.44%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
304.82%
Equity/share CAGR of 304.82% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
59.92%
Equity/share CAGR of 59.92% while OR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
22.20%
Equity/share CAGR of 22.20% while OR is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
180.39%
Dividend/share CAGR of 180.39% while OR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-67.63%
Negative near-term dividend growth while OR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
156.53%
AR growth well above OR's 9.41%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-0.03%
Negative asset growth while OR invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.42%
Positive BV/share change while OR is negative. John Neff sees a clear edge over a competitor losing equity.
-48.50%
We’re deleveraging while OR stands at 0.48%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-4.25%
We cut SG&A while OR invests at 39.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.